Ankylosing spondylitis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Ankylosing spondylitis (AS) and undifferentiated spondylarthritis (uSpA) are related inflammatory diseases affecting the spine and joints with infections among possible etiological factors.
|
31802207 |
2020 |
Ankylosing spondylitis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Ankylosing spondylitis (AS) is an inflammatory rheumatic disease with increased bone mass in the main sites of inflammation.
|
31074089 |
2020 |
Ankylosing spondylitis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Ankylosing spondylitis (AS) is an autoimmune disease with high disability rate, and it is sometimes difficult to distinguish from generalized osteoarthritis (GOA).
|
31794766 |
2020 |
Ankylosing spondylitis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Ankylosing spondylitis (AS) is a systemic inflammatory disease, and cardiac dysfunction has not been clearly described clinically.
|
30418346 |
2020 |
Ankylosing spondylitis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Ankylosing spondylitis (AS) is an inflammatory arthritis in which males have a higher risk of developing progressive axial disease than females.
|
31599089 |
2020 |
Ankylosing spondylitis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Ankylosing spondylitis (AS) is a prototype of chronic inflammatory arthritis termed seronegative spondyloarthropathies that typically affects the joints.
|
31711818 |
2020 |
Ankylosing spondylitis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Ankylosing spondylitis (AS) and gout are common inflammatory arthropathies.
|
31630236 |
2020 |
Ankylosing spondylitis
|
0.500 |
Biomarker
|
disease |
BEFREE |
In summary, we present a reliable real-time PCR protocol for HLA-B*27 screening directly in whole blood supporting fast clarification of the presence of ankylosing spondylitis or other spondyloarthritides in suspected cases.
|
31749313 |
2020 |
Ankylosing spondylitis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Ankylosing spondylitis (AS) is a chronic inflammatory joint disease that involves the entheses, causing inflammatory pain and functional impairments.
|
29787813 |
2019 |
Ankylosing spondylitis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Ankylosing spondylitis (AS) is a chronic inflammatory disease characterized with heterotopic ossification of the axis joints ligaments, resulting in joint disability.
|
31726387 |
2019 |
Ankylosing spondylitis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Ankylosing spondylitis (AS) refers to a type of arthritis manifested with chronic inflammation of spine joints. microRNAs (MiRNAs) have been identified as new therapeutic targets for inflammatory diseases.
|
31111563 |
2019 |
Ankylosing spondylitis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Considered together, the ability of both protective and disease-associated HLA-B27 allotypes to form homodimers and the failure of HLA-B*27:03 to form homodimers challenge the role of HLA-B27 homodimers in AS pathoetiology.
|
31740583 |
2019 |
Ankylosing spondylitis
|
0.500 |
Biomarker
|
disease |
BEFREE |
The mechanism of pathological osteogenesis in Ankylosing spondylitis (AS) is largely unknown.
|
31024000 |
2019 |
Ankylosing spondylitis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We aimed to present a systematic evaluation of 47 non Major Histocompatibility Complex (MHC) Ankylosing Spondylitis (AS) susceptibility loci which have been initially discovered through Caucasian Genome-wide association studies (GWASs) in Han Chinese.
|
31523044 |
2019 |
Ankylosing spondylitis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Ankylosing spondylitis (AS) is the second most common cause of inflammatory arthritis worldwide affecting the axial skeleton.
|
31124320 |
2019 |
Ankylosing spondylitis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Ankylosing spondylitis (AS) is a chronic inflammatory disease characterized by axial arthritis.
|
30777138 |
2019 |
Ankylosing spondylitis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease.
|
31432140 |
2019 |
Ankylosing spondylitis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Ankylosing spondylitis (AS) is a chronic inflammatory disease which effects cervical posture of patients.
|
31292936 |
2019 |
Ankylosing spondylitis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Ankylosing spondylitis (AS) is prototype of SpA.
|
31741083 |
2019 |
Ankylosing spondylitis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Ankylosing spondylitis (AS) is a type of rheumatic inflammatory disease. miRNAs participate in the process of regulating inflammatory response and bone differentiation.
|
31217850 |
2019 |
Ankylosing spondylitis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Ankylosing spondylitis (AS) is an inflammatory autoimmune disorder that manifested with sacroiliitis at its early stage and developed extensive inflammation with syndesmophytes of the lumbar, thoracic and cervical spines at its later stage.
|
31130248 |
2019 |
Ankylosing spondylitis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Ankylosing spondylitis (AS) is a type of chronic progressive inflammatory disease, which often causes significant damage to the patients on the physical function, labour ability and quality of life.
|
31397536 |
2019 |
Ankylosing spondylitis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Background Ankylosing spondylitis (AS) is a chronic rheumatological condition affecting sacroiliac joint and spine and occurs more often in younger patients than in the elderly population.
|
31754591 |
2019 |
Ankylosing spondylitis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Ankylosing spondylitis (AS) is a form of arthritis that can lead to fusion of vertebrae and sacroiliac joints following syndesmophyte formation.
|
31360722 |
2019 |
Ankylosing spondylitis
|
0.500 |
Biomarker
|
disease |
BEFREE |
Several other HLA-B and non-B molecules have been associated with AS, although their role in the pathogenesis is unknown.
|
31712904 |
2019 |